Live Breaking News & Updates on Roche group

Stay informed with the latest breaking news from Roche group on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Roche group and stay connected to the pulse of your community

Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer

AUSTIN, Texas, April 05, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced an analysis from the IMvigor011 study that was presented at the European Association of Urology (EAU) Congress 2024 in Paris, France. The analysis evaluates outcomes in muscle-invasive bladder cancer (MIBC) patients who tested serially negative with Signatera™, Natera’s personalized and tumor-informed molecular residual disease (MRD) test.

California , United-states , France , Paris , France-general- , San-carlos , Texas , John-simmons , Drug-administration , Clinical-laboratory-improvement-amendments , Roche-group , Genentech

Natera, Inc.: Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer

Natera, Inc.: Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

California , United-states , Paris , France-general- , France , Texas , San-carlos , Dennis-riedl , John-simmons , Mike-brophy , Lesley-bogdanow , European-association-of-urology

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LEXINGTON, Mass., April 5, 2024 /PRNewswire/ -- Curis, Inc. , a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April...

Curis-inc , Nasdaq , Genentech , Drug-administration , Prnewswire-curis-inc , Company-fourth , Roche-group , Compensation-committee , Fourth-amended , Incentive-plan , Aim-lymphoma

Curis, Inc.: Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Curis, Inc.: Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis-riedl , Roche-group , Nasdaq , Curis-inc , Genentech , Prnewswire-curis-inc , Drug-administration , Company-fourth , Compensation-committee , Fourth-amended , Incentive-plan

Natera (NTRA) Reports Positive Surveillance Analysis from Phase III IMvigor011 Trial

Natera (NTRA) Reports Positive Surveillance Analysis from Phase III IMvigor011 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Paris , France-general- , France , John-simmons , Drug-administration , European-association-of-urology , Genentech , Nasdaq , Natera-inc , Roche-group , European-association , Professor-powles

Curis to Present at Upcoming Healthcare Conferences in April

LEXINGTON, Mass., April 4, 2024 /PRNewswire/ -- Curis, Inc. , a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James...

James-dentzer , Company-presentation , Curis-inc , Prnewswire-curis-inc , Drug-administration , Genentech , Roche-group , Nasdaq , Chief-executive-officer , Annual-needham-virtual-healthcare-conference , Aim-lymphoma , Aim-leukemia

Opthea Appoints Sujal Shah to the Board of Directors

Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee ChairMELBOURNE, Australia and PRINCETON, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced the appointment

Australia , Melbourne , Victoria , Silvana-guerci-lena , Dan-spiegelman , Jeremy-levin , Sujal-shah , Fred-guerard , Daniel-spiegelman , Risk-committee-chairman , Exchange-commission , Investment-in-biotechnology-companies

Opthea Appoints Sujal Shah to the Board of Directors

Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee Chair...

Australia , Melbourne , Victoria , Dan-spiegelman , Sujal-shah , Daniel-spiegelman , Jeremy-levin , Silvana-guerci-lena , Fred-guerard , Genentech-united-states-inc , Carnegie-mellon-university-tepper-school-of-business , Company-board-of-directors-the

Opthea Appoints Sujal Shah to the Board of Directors

Opthea Appoints Sujal Shah to the Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Melbourne , Victoria , Australia , Fred-guerard , Daniel-spiegelman , Sujal-shah , Jeremy-levin , Dan-spiegelman , Exchange-commission , Investment-in-biotechnology-companies , Risk-committee-chairman , Northwestern-university

Opthea Appoints Sujal Shah to the Board of Directors

Opthea Appoints Sujal Shah to the Board of Directors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Australia , Melbourne , Victoria , Daniel-spiegelman , Silvana-guerci-lena , Jeremy-levin , Fred-guerard , Sujal-shah , Dan-spiegelman , Investment-in-biotechnology-companies , Opthea-limited , Company-board-of-directors-the